No. of Pages: 181 | Report Code: BMIRE00026298 | Category: Life Sciences
公司正在进行许多研发活动以引入先进的 HPV 检测。例如，2021 年 5 月，领先的医疗技术公司 BD 推出了首个带有 CE 标记的检测方法，用于在家中自行采集的阴道样本中进行 HPV 筛查。这使得实验室能够通过 BD 稀释管处理自行收集的样品。在家采集样本将有助于解决未参加常规宫颈癌筛查的女性面临的紧迫公共卫生挑战。此外，2020 年 9 月，该地区的药物管理局批准扩大使用 F. Hoffmann-La Roche Ltd 的 CINtec PLUS Cytology，这是第一个基于生物标志物技术的分类测试，适用于宫颈癌筛查结果为高危类型阳性的女性人乳头瘤病毒（HPV）。 CINtec PLUS 细胞学测试可识别单个细胞中同时存在的两种生物标志物——p16 和 Ki-67。这种异常与 HPV 感染有关，如果不治疗，HPV 感染会进展为癌前病变或癌症。这两种生物标志物的阳性结果表明患病的风险更大。 HPV 诊断测试的强劲发展很可能会在预测期内重塑 HPV 疫苗市场。
凭借新功能和技术，供应商可以吸引新客户并扩大规模他们的足迹遍布新兴市场。这一因素可能会推动亚太地区人乳头瘤病毒 (HPV) 疫苗市场。 亚太地区人乳头瘤病毒 (HPV) 疫苗市场预计在预测期内将以良好的复合年增长率增长。
亚太地区人乳头瘤病毒 (HPV) 疫苗市场根据类型、剂量、年龄、应用、最终用户和国家/地区进行细分。根据类型，亚太地区人乳头瘤病毒（HPV）疫苗市场分为9价HPV疫苗、四价HPV疫苗和二价HPV疫苗。四价 HPV 疫苗在 2022 年占据市场主导地位。根据剂量，亚太地区人乳头瘤病毒 (HPV) 疫苗市场分为 2 剂和 3 剂。 2022 年，2 剂量细分市场占据主导地位。 根据年龄，亚太地区人乳头瘤病毒 (HPV) 疫苗市场分为 9 至 14 岁和 15 至 45 岁。 2022 年，9 至 14 岁细分市场占据主导地位。根据应用情况，亚太地区人乳头瘤病毒 (HPV) 疫苗市场分为 HPV 相关癌症和生殖器疣。 HPV 相关癌症细分市场在 2022 年占据主导地位。根据最终用户，亚太地区人乳头瘤病毒 (HPV) 疫苗市场分为医生办公室、社区卫生诊所、学校卫生中心、卫生部门、医院等。医院细分市场在 2022 年占据主导地位。按国家/地区划分，亚太地区人乳头瘤病毒 (HPV) 疫苗市场分为中国、日本、印度、澳大利亚、东南亚、新西兰、韩国和亚太地区其他地区。 2022年中国将占据市场主导地位。
成都生物制品研究所有限公司；葛兰素史克公司；伊诺维奥制药公司；默克公司有限公司； R-Pharm；赛诺菲；印度血清研究所列兵。有限公司；疫苗科技；沃森生物科技有限公司；和厦门万泰生物科技有限公司。 是亚太地区人乳头瘤病毒 (HPV) 疫苗市场的领先公司之一。
Strategic insights for Asia Pacific Human Papillomavirus (HPV) Vaccine involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 567.57 Million |
| Market Size by 2028 | US$ 826.34 Million |
| Global CAGR (2022 - 2028) | 6.5% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Human Papillomavirus (HPV) Vaccine refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Human Papillomavirus (HPV) Vaccine Market is valued at US$ 567.57 Million in 2022, it is projected to reach US$ 826.34 Million by 2028.
As per our report Asia Pacific Human Papillomavirus (HPV) Vaccine Market, the market size is valued at US$ 567.57 Million in 2022, projecting it to reach US$ 826.34 Million by 2028. This translates to a CAGR of approximately 6.5% during the forecast period.
The Asia Pacific Human Papillomavirus (HPV) Vaccine Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Human Papillomavirus (HPV) Vaccine Market report:
The Asia Pacific Human Papillomavirus (HPV) Vaccine Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Human Papillomavirus (HPV) Vaccine Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Human Papillomavirus (HPV) Vaccine Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Human Papillomavirus (HPV) Vaccine Market
